Chemotherapy is set to become better at treating cancer, while also carrying fewer debilitating side effects, thanks to a new drug delivery method which has been developed by a chemistry professor ...

Earlier this week, it was announced that King Charles III was forced to cancel public events after suffering side effects of his cancer treatment. The 76-year-old monarch was diagnosed with an ...

Avastin has interactions with some other drugs and certain vaccines ... in addition to chemotherapy, may increase the risk for side effects of Avastin or panitumumab. That said, guidelines ...

Anaemia: Chemotherapy can reduce the number of red blood cells, causing fatigue and weakness. Nausea and Vomiting: Common side effects that can usually be managed with medications. Hair Loss ...

Chemo drugs can't tell the difference, and they also kill healthy cells, causing many different side effects during treatment ...

Cancer drugs you take ... your IT chemo might include trastuzumab, a biologic that targets breast cancer in particular. About 30% of people will have some side effects after IT chemo.

At present, most chemotherapy drug treatments ... but he has also avoided the side effects that can go with intravenous therapy. A drip provides the drug in a very concentrated form, but the ...

Drug rashes can be an unwanted side effect of many medications. Learn which medications can cause these skin reactions.

maximizing drug delivery to the tumors without adding systemic side effects. A team led by Dr. Iswanto Sucandy, a board-certified surgeon with dual fellowship training in Hepatobiliary and ...

Researchers at Bristol University have created a lay summary for their research. The project will investigate the mechanisms of a new clinical drug combination currently in clinical trials for breast ...

Telomir-1 demonstrated the opposite effect when used in conjunction with a widely used chemotherapy drug known as Paclitaxel ... and contributes to severe side effects. Metal ions, such as iron ...

Despite solid data, the lack of high-value indications and no unique platform makes Nuvalent's valuation seem inflated; I ...